Esophageal Cancer Market is predominantly driven by the Rising Product Innovations; MRFR Reveals Insights for 2021 – 2027

The global esophageal cancer market is growing considerably and is expected to reach USD 1000.1 Million by the end of 2023 and progress at a CAGR of 8.7% over the forecast period of 2017-2023, reveals Market Research Future (MRFR) in an exhaustive study. The market has been observing persistent growth on account of rising prevalence of esophageal cancer among the global population which results in diagnosis and treatment. Esophageal cancer is more common in aged people, and thus a growth in the global geriatric population spurs the growth of the market. High consumption of alcohol and smoking habits among the mass drive the market growth as smoking and drinking expose consumers at more risk of developing esophageal cancer. Moreover, the high prevalence of digestive disorders is also responsible for the growth of the market. Acid reflux is a major cause of esophageal cancer, and continuous acid reflux can result in esophageal cancer. Advancements in medical procedures and development of new therapies and drugs have also been a plus for the market growth. Government support for raising awareness and monetary aids to patients struggling with overwhelming costs of the treatment along with free treatment is among other factors proving vital for the growth of the market. The rise in a number of clinical activities and rise in a number of approvals provided by FDA for novel drugs and therapies aimed at the treatment of esophageal cancer also adds fuel to the growth of the market. 

Get Request Free Sample @ https://www.marketresearchfuture.com/sample_request/3280

Segmentation

The global esophageal cancer market has been segmented based on type, phases, and treatment. By type, the market has been segmented into esophageal squamous-cell carcinoma, esophageal adenocarcinoma, and others. By phases, the market has been segmented into phase I, phases II and phases III. By treatment, the market has been segmented into surgery, chemotherapy and radiotherapy and others.

Regional Analysis:

The comprehensive geographical study of the global esophageal market spans across North America, Europe, Asia Pacific, and the Middle East Africa (MEA). North America is highly affected by the addiction of tobacco and other drugs which is expected to support the growth of the patient population. It is anticipated to catalyze the growth of the esophageal cancer market in the region. In addition, the support provided by the government for research development of effective drugs is expected to propel market expansion over the next couple of years.

Europe is anticipated to maintain its prominence at the second spot through the assessment period. The region is poised to exhibit a rise in research development. It is likely to favor growth of the regional esophageal market. In addition, Asia Pacific signifies developmental opportunities owing to the presence of a huge patient population.

Competitive Landscape

Amgen Inc. (U.S.), Boehringer Ingelheim GmbH (Germany), Johnson Johnson (U.S.), Eli Lilly and Company (U.S.), Merck Co., Inc. (U.S.), F. Hoffmann-La Roche (Switzerland), Novartis AG (Switzerland), GlaxoSmithKline Plc. (U.K), Bristol-Myers Squibb (U.S.), Bristol-Myers Squibb Company (U.S.), and Gilead Sciences, Inc. (U.S.) are the eminent players in the global esophageal cancer market.

Industry Updates

August 2019 - A new immunotherapy drug has been approved by the U.S. Food and Drug Administration (FDA) aimed at treating esophageal cancer. Dubbed as “Keytruda", the new immunotherapy drug pembrolizumab has exhibited its efficiency in reducing the risk of fatality in esophageal cancer patients by 31% in clinical trials. The treatment would be beneficial for those patients who are unresponsive to chemotherapy. Keytruda is the result of aggressive RD by the leading pharmaceutical company, Merck Co.

1 INTRODUCTION

1.1 DEFINITION

1.2 SCOPE OF STUDY

1.2.1 RESEARCH OBJECTIVE

1.2.2 ASSUMPTIONS LIMITATIONS

1.2.2.1 ASSUMPTIONS

1.2.2.2 LIMITATIONS

1.3 MARKET STRUCTURE:

2 RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS:

2.2 PRIMARY RESEARCH

2.3 SECONDARY RESEARCH:

3 MARKET DYNAMICS

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 MACROECONOMIC INDICATORS

4 MARKET FACTOR ANALYSIS

4.1 PORTERS FIVE FORCES MODEL

4.2 BARGAINING POWER OF SUPPLIERS

4.3 BARGAINING POWER OF BUYERS

4.4 THREAT OF NEW ENTRANTS

4.5 THREAT OF SUBSTITUTES

4.6 INTENSITY OF RIVALRY

5 GLOBAL ESOPHAGEAL CANCER MARKET, BY TYPE

5.1 ESOPHAGEAL SQUAMOUS-CELL CARCINOMA, ,

5.2 ESOPHAGEAL ADENOCARCINOMA

5.3 OTHERS

Browse Complete Report with TOC @ https://www.marketresearchfuture.com/reports/esophageal-cancer-market-3280

Related reports link:-

Dry Mouth Relief Market
Remdesivir (Covid 19) Market
Healthcare Claims Management Market

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

https://marketreports4u.blogspot.com/